ストックスクリーナーアプリを入手
1.44
1.37%
-0.02
アフターアワーズ：
1.45
0.01
+0.69%
前日終値:
$1.46
開ける：
$1.46
24時間の取引高:
94,896
Relative Volume:
0.25
時価総額：
$24.01M
収益：
$4.70M
当期純損益:
$-14.30M
株価収益率:
-1.1717
EPS:
-1.229
ネットキャッシュフロー:
$-14.82M
1週間 パフォーマンス:
-13.25%
1か月 パフォーマンス:
-21.31%
6か月 パフォーマンス:
+12.50%
1年 パフォーマンス:
-9.43%
1日の値動き範囲:
$1.41
$1.49
1週間の範囲:
$1.335
$1.77
52週間の値動き範囲:
$0.8099
$4.07
Marker Therapeutics Inc Stock (MRKR) Company Profile
名前
Marker Therapeutics Inc
セクター
電話
(713) 400-6400
住所
2450 HOLCOMBE BLVD, HOUSTON, TX
Compare MRKR vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MRKR
Marker Therapeutics Inc
|
1.44 | 24.34M | 4.70M | -14.30M | -14.82M | -1.229 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Marker Therapeutics Inc Stock (MRKR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-05 | 開始されました | Canaccord Genuity | Buy |
| 2021-03-25 | 開始されました | Piper Sandler | Overweight |
| 2021-03-19 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-05-12 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2019-05-30 | 開始されました | ROTH Capital | Buy |
| 2019-03-01 | 開始されました | Janney | Buy |
| 2018-12-03 | アップグレード | Piper Jaffray | Neutral → Overweight |
すべてを表示
Marker Therapeutics Inc (MRKR) 最新ニュース
Marker Therapeutics sets date for 2026 annual shareholder meeting and proposal deadline By Investing.com - Investing.com South Africa
Marker Therapeutics sets date for 2026 annual shareholder meeting and proposal deadline - Investing.com
Marker Therapeutics Sets Date for 2026 Annual Meeting - TipRanks
Portfolio Update: Why is Mattel Inc stock going upJuly 2025 Market Mood & Reliable Breakout Stock Forecasts - baoquankhu1.vn
Marker Therapeutics, Inc. (NASDAQ:MRKR) Given Average Rating of “Moderate Buy” by Analysts - Defense World
Can BioSig Technologies Inc benefit from deglobalizationPortfolio Performance Report & Safe Entry Trade Reports - baoquankhu1.vn
Good Morning America Features Baylor College of Medicine Pancreatic Cancer Study Utilizing Marker Therapeutics’ MAR-T Cell Technology - manilatimes.net
Good Morning America puts Baylor T-cell cancer trial in national spotlight - Stock Titan
Good Morning America Features Baylor College of Medicine - GlobeNewswire
Institution Moves: Should I trade or invest in One Liberty Properties IncJuly 2025 Earnings & Precise Swing Trade Alerts - baoquankhu1.vn
MRKR stock up nearly 114% in 3 months: Here's what you need to know - MSN
MRKR Stock Up Nearly 114% in 3 Months: Here's What You Need to Know - Finviz
Risk Analysis: Can Marker Therapeutics Inc outperform in the next rallyJuly 2025 Decliners & Entry Point Confirmation Alerts - baoquankhu1.vn
Published on: 2026-01-20 15:10:37 - baoquankhu1.vn
Whale Trades: Does REBN have consistent dividend growthTrade Risk Report & Weekly Hot Stock Watchlists - baoquankhu1.vn
Marker Therapeutics (NASDAQ:MRKR) Cut to “Hold” at Zacks Research - Defense World
Jobs Data: Can PGHL disrupt its industryLayoff News & Daily Oversold Stock Bounce Ideas - baoquankhu1.vn
Bearish Setup: Is Marker Therapeutics Inc a strong candidate for buy and holdJuly 2025 Final Week & AI Enhanced Trading Signals - baoquankhu1.vn
Is Marker Therapeutics Inc. on track to beat earningsPortfolio Update Report & Weekly Watchlist of Top Performers - bollywoodhelpline.com
Here's Why We're Watching Marker Therapeutics' (NASDAQ:MRKR) Cash Burn Situation - Sahm
Insider Trends: Will Marker Therapeutics Inc. stock benefit from commodity pricesWeekly Investment Recap & Low Risk Profit Maximizing Plans - Улправда
How sustainable is Marker Therapeutics Inc. stock dividend payout2025 Year in Review & Safe Capital Growth Plans - Улправда
Short Interest Drops in Twinstar Industries Limited After RallyJuly 2025 Opening Moves & Low Volatility Stock Suggestions - Улправда
Will Marker Therapeutics Inc. stock benefit from green energy trendsSell Signal & Real-Time Chart Pattern Alerts - Улправда
How strong is Marker Therapeutics Inc. stock balance sheetWeekly Risk Report & Stepwise Entry and Exit Trade Signals - Улправда
Will NEXT plc (NXG) stock gain from green policiesJuly 2025 Earnings & Intraday High Probability Setup Alerts - Улправда
Can Marker Therapeutics Inc. stock sustain market leadership2025 Investor Takeaways & AI Powered Buy/Sell Recommendations - Улправда
Why Marker Therapeutics Inc. (GX1) stock could rally stronglyDay Trade & Verified High Yield Trade Plans - Улправда
Will Marker Therapeutics Inc. stock benefit from commodity pricesTrade Volume Report & Free Community Consensus Stock Picks - Улправда
Why Marker Therapeutics Inc. stock remains on buy listsJuly 2025 Earnings & Fast Exit and Entry Trade Guides - Улправда
Zacks Industry Outlook Highlights Soleno Therapeutics, Nektar Therapeutics, Rigel Pharmaceuticals, Ironwood Pharmaceuticals and Marker Therapeutics - Yahoo Finance
Breakouts Watch: How strong is Marker Therapeutics Inc. stock balance sheetWeekly Loss Report & Fast Entry High Yield Stock Tips - Bộ Nội Vụ
MARKER THERAPEUTICS, INC. (MRKR) Now Trades Above Golden Cross: Time to Buy? - sharewise.com
Marker Therapeutics, Inc. (MRKR) now trades above golden cross: Time to buy? - MSN
Marker Therapeutics announces publication on MAR-T cells in pancreatic cancer - MSN
Marker Therapeutics stock maintains Buy rating at H.C. Wainwright By Investing.com - Investing.com Canada
Is Marker Therapeutics Inc GX1 a good long term investmentMarket Sentiment Shifts & Buy Sell Signal Notifications - earlytimes.in
สล็อต www.mio555.com - earlytimes.in
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Brookline Capital raises Marker Therapeutics stock price target to $5.60 By Investing.com - Investing.com Canada
Marker Therapeutics Reports Positive Phase 1/2 Clinical Study Results for Multi-Antigen Targeted T Cells in Pancreatic Cancer Patients - Quiver Quantitative
Baylor College of Medicine Publishes Promising Safety and Efficacy Results of Multi-Antigen Targeted T Cells in Patients with Pancreatic Cancer - The Manila Times
Baylor College of Medicine Publishes Promising Safety and - GlobeNewswire
Wall Street Zen Upgrades Marker Therapeutics (NASDAQ:MRKR) to Hold - Defense World
MRKR stock touches 52-week low at $1.8 amid market challenges - MSN
Why Marker Therapeutics Inc stock remains undervaluedMarket Trend Review & Verified Stock Trade Ideas - moha.gov.vn
Trade Recap: How Marker Therapeutics Inc GX1 stock reacts to monetary easing2025 Major Catalysts & Smart Investment Allocation Tips - moha.gov.vn
Nasdaq Moves: Is Mineralys Therapeutics Inc stock a safe investment in uncertain marketsJuly 2025 Outlook & Real-Time Volume Spike Alerts - moha.gov.vn
MRKR stock touches 52-week low at $2.4 amid challenging year - MSN
Technical Analysis: Amber Enterprises India Limited (AMBER)Stock Correlation Metrics & Superior Return Stocks - bollywoodhelpline.com
Moving Average Crossover Confirms Uptrend in Dharani Sugars and Chemicals LimitedEnergy Sector Updates & Interactive Charts for Smarter Trading - bollywoodhelpline.com
Marker Therapeutics Inc (MRKR) 財務データ
収益
当期純利益
現金流量
EPS
1.24%
0.19%
大文字化:
|
ボリューム (24 時間):